Stockreport

GRI Bio Announces Korea Patent Granted for Proprietary Natural Killer T (NKT) Cell Modulators [Yahoo! Finance]

GRI Bio, Inc.  (GRI) 
PDF LA JOLLA, CA, June 27, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Na [Read more]